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ABSTRACT
Purpose Measurement of the second virial coefficient B22 for
proteins using self-interaction chromatography (SIC) is be-
coming an increasingly important technique for studying their
solution behaviour. In common with all physicochemical
chromatographic methods, measuring the dead volume of
the SIC packed column is crucial for accurate retention data;
this paper examines best practise for dead volume
determination.
Method SIC type experiments using catalase, BSA, lysozyme
and amAb as model systems are reported, as well as a number
of dead column measurements.
Results It was observed that lysozyme and mAb interacted
specifically with Toyopearl AF-Formyl dead columns de-
pending upon pH and [NaCl], invalidating their dead
volume usage. Toyopearl AF-Amino packed dead col-
umns showed no such problems and acted as suitable
dead columns without any solution condition dependen-
cy. Dead volume determinations using dextran MW
standards with protein immobilised SIC columns provided
dead volume estimates close to those obtained using
Toyopearl AF-Amino dead columns.
Conclusion It is concluded that specific interactions between
proteins, including mAbs, and select SIC support phases
can compromise the use of some standard approaches
for estimating the dead volume of SIC columns. Two oth-
er methods were shown to provide good estimates for the dead
volume.
KEY WORDS dead volume . mAbs . protein-protein
interactions . second virial coefficient . self-interaction
chromatography
ABBREVIATIONS
B2 Dimensionless Second Virial Coefficient
B22 Osmotic Second Virial Coefficient
BSA Bovine Serum Albumin
LC Liquid Chromatography
mAb Monoclonal Antibody
SEC Size-Exclusion Chromatography
SIC Self-Interaction Chromatography
INTRODUCTION
Monoclonal antibodies (mAbs) have successfully been used in
clinical trials for treatments of several cancer and autoimmune
diseases (1–3) and have lately become the fastest growing seg-
ment of the biopharmaceutical industry (4, 5). Currently 48
therapeutic monoclonal antibodies are approved or in review
by the EU or the USA. They are represented as the second
largest biopharmaceutical category under investigation as
therapeutic drugs and have therefore become vitally impor-
tant for modern medicine (6). The manufacture of mAbs in a
cost-effective and reliable fashion still remains a major inter-
national challenge in spite of the success antibody therapeutics
have had in the pharmaceutical industry (7, 8).
The current understanding about the way mAbs behave in
different solution conditions, and the specifically the effects of
solution conditions on formulation stability is still not
fully understood, especially in terms of the mechanisms lead-
ing to aggregation and their long-term aggregation stability (9,
10). Therapeutic proteins such as mAbs have complex struc-
tures and often have relatively large molecular sizes, so when
they are exposed to certain solution conditions they are prone
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to physical instability and tend to aggregate (11, 12). In order
to minimise the problems associated with aggregation in
bioprocessing, the ability to predict, for complex proteins such
as mAbs both their propensity to aggregation as well as aggre-
gation rates would be a valuable tool in process and formula-
tion development (13). Another key challenge in protein for-
mulation is viscosity, especially when proteins are present in
higher concentrations as is the case of therapeutic drugs re-
quiring high dosages (14).
Protein-protein intermolecular interactions are known to
be involved in protein solution aggregation behaviour (15).
However, the exact mechanisms leading to protein aggrega-
tion are still not fully understood (15–17). The osmotic second
virial coefficient (B22) is a fundamental physiochemical prop-
erty that describes protein-protein interactions in solution and
can be a useful tool for predicting the aggregation propensity
of proteins as well as other solution conditions such as those
suitable for protein crystallisation. Quigley and Williams (18)
have reported an extensive B22 study over a range of proteins
in aqueous solutions across a wide range of pH’s and salt
concentrations. This work showed that the osmotic second
virial coefficient, B22, was an accurate descriptor of protein
aggregation behaviour in terms of hydrodynamic radius for
a number of model proteins.
B22 comes from the virial equation of state, which describes
the behavior of non-ideal gases (real gases). A solution ther-
modynamic model of the intermolecular forces between gas
molecules can also be applied analogously to solvent mole-
cules interacting with proteins in solution, and is known as
the McMillan and Mayer theory (19). B22 describes non-
ideal solution behaviour and can be used to quantify intermo-
lecular forces between two protein molecules (20). B22 de-
scribes the direction and magnitude of overall intermolecular
forces, in which positive B22 values represent net repulsive
forces where protein-solvent interactions are favoured, while
negative B22 values indicate net attractive forces where
protein-protein interactions are favoured, which cause aggre-
gation to occur.
The first experimental techniques employed to determine
B22 were membrane osmometry and static light scattering,
though both of these techniques require several solution con-
centrations to determine a single B22 value. Additionally, these
techniques can be time consuming and require relatively large
amounts of protein for reliable B22 estimates (21). Self-
Interaction chromatography (SIC) is a relatively new
technique and was first reported by Patro and Przybycien
(22) who used it to predict protein aggregation. SIC involves
immobilising a target protein onto a solid state material which
is usually a chromatographic stationary phase. The same pro-
tein will then be used within the mobile phase as well, and a
pulse of protein (together with buffer) will be injected and
eluted through the packed column which contains the
immobilised protein. The elution behaviour, and specifically
the elution volume for the protein which passes through the
column packed with the immobilised protein are accurately
measured, normally using a UV–Vis LC detector. The chro-
matographic measurement of the retention volume between
the protein in the mobile phase and the protein immobilised
on the stationary phases forms the basis of SIC.
This type of chromatography is based on weak affinity
chromatography principles, but in this technique the same
protein will both act as ligand and ligate. Tessier et al.
(23) developed a model from the SIC method described by
Patro and Przybycien (22), and an expression for the interac-
tion between two protein molecules in solution in terms of the
osmotic B22 as originally presented by Zimm (24) and
McQuarrie (25) for determination of B22. The model is based
on a statistical mechanics based analysis. The net retention
volume data represents the protein-protein interactions, and
is used together with the excluded volume contributions, the
phase ratio and the number of immobilised protein molecules
per unit area. Over the following decade, the technique con-
tinued to be developed and has been applied to a number of
model and therapeutic proteins, many employing the same
experimental immobilisation methods as described originally
by Tessier et al. (23). SIC has more recently become a
technique being used for studying therapeutic proteins.
Payne et al. (26) were the first to use SIC for the determina-
tion of B22 for a therapeutic peptide that would not scatter
light sufficiently to be studied using static light scattering
(SLS). Le Brun et al. (27), Lewus et al. (28) and Ahamed et al.
(29) have investigated B22 for monoclonal antibodies,
reporting the effects of ionic strength and pH, but also the use
of co-solvents such as PEG (28, 29) and temperature variations
(27). Correlations of B22 with both solubility and crystallisation
behaviour have been reported (30–36) as well as models created
for best formulation conditions (37). Correlations between
aggregation and B22 have also been reported using experimen-
tal techniques other than SIC (38). Another technique reported
includes dynamic light scattering that can determine the
protein-protein interaction parameter in quite a high-
throughput manner and has also proved useful in formulation
development (39).
Determination of the Second Virial Coefficient
The dead volume is defined as the interstitial space between
the particles in the column as well as any other volume in the
column and tubing that is not packed. In order to determine
B22, the dead volume or the volume required for a non-
interacting molecule of the same size as the protein to pass
through the SIC column needs to be accurately measured.
The non-interactingmolecule used for this measurement must
be carefully chosen. Not only must this molecule not interact
specifically with the immobilised protein or the phase it is
immobilised on, but it should also sense the same volume
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within the stationary phase that would be sensed by a protein
eluted via the mobile phase. So, for example, it cannot just be
any non-interacting molecule such as acetone because protein
molecules are not able to access as much of the pore space in
the immobilised phase as can smaller molecules such as ace-
tone. This size exclusion effect has been argued to be a reason
not to use acetone retention volumes as a dead volume mea-
sure (23). In the literature, the dead volume has been deter-
mined using two main methods.
The first procedure evaluated by Tessier et al. (23) involved
using a dead column, which is a SIC column prepared in the
same way without immobilising the protein on the support,
and measuring the retention volume of both acetone (V’a) and
protein (V’p) passing through the dead column. The dead
volume, V0, can then be estimated by:
V 0 ¼ V a V
0
p
V
0
a
 
−V i ð1Þ
where Vi is the volume occupied by the immobilised protein
molecules and Va is the acetone retention volume in the
immobilised column. For the latter calculation protein mole-
cules are assumed to be spherical and the diameter is calcu-
lated from the molecular volume, described by Neal and
Lenhoff (40).
The second experimental procedure for determining the
dead volume was proposed by Binabaji et al. (41), which in-
volved using dextran molecules of different molecular weights
as the dead volumemarker. They determined that the dextran
standard that had the retention volume closest to the mAb of
142 kDa using a Superdex 200 column served as the non-
interacting solute and would be then used to estimate V0. In
their study this solute was a 50 kDa dextranMW standard and
this dextran was injected onto the mAb immobilised column
to directly determine V0.
Then B22 can be obtained by the equation:
B22 ¼ N A
M2W
BHS−
k
0
ρsΦ
 !
ð2Þ
where
k
0 ¼ V p− V 0
V 0
ð3Þ
k′ is a chromatographic retention factor where VP is defined as
the retention volume of the protein in the protein immobilised
column. BHS in Eq. 2 is defined as the excluded volume or the
hard sphere contribution defined by 163 πr
3 using the protein
radius. ρs is defined as the number of immobilised molecules
per unit area and obtained by dividing the concentration of
immobilised protein by the porosity (0.811 for the 650 M
resin) and the phase ratio (Φ) of one protein molecule. The
phase ratio is given by As / V0 where As is the total accessible
surface area, which is available to the mobile phase protein.
This data was calculated by using inverse size exclusion chro-
matography data for different size dextran molecules for a
variety of particles presented by DePhillips and Lenhoff (42).
B22 as specified above is dependent on the molecular
weight of the protein, so in order to more accurately present
the results and compare B22 results between different proteins
the dimensionless second virial coefficient (B2) is used. B2 can
be obtained from B22 through the following equation (43):
B2 ¼ B22M
2
W
N ABHS
ð4Þ
The retention times for the protein and acetone injections
on all column were determined using first moment (centre of
mass) approach recommended by Quigley et al. (44). The re-
tention times using this technique were compared to those
determined by peak maximum. In cases where the chromato-
grams were Gaussian shaped the first moment analysis and
peak maximum retention times/volumes will be coincident.
For acetone injections the chromatograms were almost
completely Gaussian, which resulted in similar results for both
methodologies. However, for protein injections many chro-
matograms showed tailed peaks, confirming the importance
of a first moment analysis as used here.
A key challenge that remains in evaluating B2 accurately is
estimating the dead volume (41). This important topic has
received limited attention, and in the previous literature very
few details on how the dead volume in the dead columns were
determined in terms of key variables such as solution condi-
tions are reported (23). The objective of this work is to criti-
cally evaluate the techniques previously described for estimat-
ing the dead volume in SIC and, applying the best practise
dead volumes corrections, so as to calculate B2 for a mAb in
conditions where it is known to have poor solution stability.
MATERIALS AND METHODS
Materials and Equipment
Experiments with the model proteins were performed with
hen egg white lysozyme (crystalline white powder, EC
3.2.1.17), bovine liver catalase (lyophilised powder, EC
1.11.1.6), bovine serum albumin (BSA), (lyophilised powder,
A-7638) all obtained from Sigma-Aldrich (Dorset, UK) and a
monoclonal antibody of IgG1 type supplied by FUJIFILM
Diosynth Biotechnologies which was highly purified
(pI of 8.6 and molecular weight 144.5 kDa). The dextran
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molecular weight standards were obtained from Sigma-
Aldrich. The 50 kDa standards (00891 and 31420) had a
polydispersity index of <1.5. Potassium phosphate,
NaBH3CN, dibasic and monobasic sodium phosphate, etha-
nolamine, HCl and NaOH were all purchased from Sigma-
Aldrich (ACS or BioXtra grade). NaCl, Sodium acetate
trihydrate, glacial acetic acid and acetone were obtained from
Fisher Scientific (AR grade). Toyopearl AF-Formyl-650 M
(08004) and Toyopearl AF-Amino-650 M particles (08002)
were purchased from Tosoh Bioscience. For buffer prepara-
tion ultrapure deionised water (resistivity ~18.2 MΩ∙cm) was
used. The pH of the buffers were adjusted withHCl or NaOH
and monitored using a Mettler Toledo FiveEasy pH meter.
All solutions were filtered using 0.22 μm bottle-top filters from
Millipore in order to remove particulates before analysis.
Self-Interaction Chromatography (SIC) experiments were
performed using an Agilent 1100 series liquid chromatograph
(Agilent Technologies, Cheshire, UK). Themodel consisted of
a binary solvent pump, an autosampler, with a sample
injection valve, a thermo stated column compartment
and two variable wavelength UV/Vis detectors, one
placed before the column and one after. Having a UV
detector both before and after the column enables determina-
tion of any protein being irreversibly bound to the column or
protein being lost from the column due to denaturation.
Buffers entering the system were filtered through inlet filters,
and the dissolved air in the solvents was removed with a
Phenomenex Degassex vacuum four-channel on-line degasser
(Phenomenex, Torrence, CA). The liquid chromatography
system was controlled and data was collected using
Chemstation software version A.10.02 for HPLC systems
(Agilent Technologies, Cheshire, UK). The particles with
immobilised proteins, serving as the stationary phase, were
slurry packed into an empty glass column, 100 mm long with
an internal diameter of 6.6 mm from Omnifit with one fixed
and one adjustable end piece pre-assembled with 25 μm PE
frits (Fisher Scientific).
Preparation of Dead Columns
The traditional dead column preparation consisted of packed
columns prepared in the same way as a normal SIC without
protein immobilised on them.Other workers have not directly
considered the possible specific interactions between the dead
column materials and the target proteins. These specific inter-
actions could arise from the covalent bonding that can occur
between the resin and the proteins.
In past immobilisation procedures reported for lysozyme
and mAb, the protein amine groups form covalent bonds with
the formyl or aldehyde groups on the Toyopearl AF-Formyl
particles. In the same way the amine groups available on the
Toyopearl AF-Amino particles form covalent bonds with
carboxyl groups or aldehyde groups on the proteins, which
is the case for catalase and BSA.
The dead columns prepared in this study consisted of
Toyopearl AF-Formyl particles and AF-Amino particles with-
out immobilised proteins. At least two of each column type
was prepared to test data reproducibility. The Toyopearl AF-
Formyl columns were prepared both with and without the
addition of ethanolamine and sodium cyanoborohydride,
NaBH3CN, to see if the addition of these reagents produced
any difference in results. The Toyopearl AF-Amino columns
were prepared the same way without any addition of reagents.
Immobilisation and Column Packing
The immobilisation of mAb were carried similarly to the pro-
cess described by Tessier et al. (23). Three ml of Toyopearl AF-
Formyl particles were first washed with 250 ml of deionised
water on a glass frit with a 0.2 μmpolyethersulfonemembrane
filter (Sigma-Aldrich) and then mixed with mAb at a concen-
tration of 10 mg/ml in 0.1 M potassium phosphate buffer.
Afterwards, 90 mg of NaBH3CN was added to the suspension
and the reaction was left to proceed overnight on a rotary
mixer. The next day the particles were washed with 0.1 M
potassium phosphate buffer and the remaining active sites
were capped using 20 mg of cyanoborohydride and 15 ml of
1 M ethanolamine. The reaction was finally allowed to pro-
ceed for at least 4 h on a rotary mixer.
The protein immobilised particles were then slurry packed
into an empty column and washed in situ with 100 ml of 0.1 M
potassium phosphate, then with approximately 100 ml of 1 M
NaCl and once again with approximately 100 ml 0.1 M po-
tassium phosphate. The washes were performed to remove
any protein not covalently bound to the stationary phase
and all the washes were collected (from the initial protein
solution to the final washes in situ) in order to calculate the
net amount of protein immobilised on the stationary phase
using mass balance. The concentration of residual protein
found in the washes was determined by UV spectroscopy at
280 nm and a BCA protein assay.
Before any SIC experiments with protein were performed,
a 50 μl pulse of 2% v/v aqueous solution of acetone was
injected through the column and the peak was analysed for
symmetry. The aim is to obtain sharp Gaussian peaks to indi-
cate that the column is properly packed without any channel-
ling occurring. For the SIC experiments the same protein as
immobilised on the column was dissolved in selected buffer
solutions in glass vials in the autosampler and is referred to as
the protein mobile phase. The buffer used for the protein
mobile phase was always the same buffer as being pumped
through the system.
The column was conditioned with buffer of the same pH as
was going to be used in the experiments. Experiments were
not initiated until the UV baselines from the detectors were
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stable. Before any injections were made an equilibration time
of 30 min was allowed. An experimental run consisted of
injecting a pulse of the protein mobile phase and monitoring
the absorbance until all the protein had eluted through the
column. All injections were repeated in triplicates to ensure
reliability of the results. The injection sizes were 10 μl for the
model proteins and 20 μl for the mAb, the injection concen-
trations were 10 mg/ml for lysozyme, BSA and mAb, and
3 mg/ml for catalase. The flow rate was 0.5 ml/min and the
buffer conditions were 20 mM sodium acetate for pH 4.5–5.0
and 20 mM sodium phosphate for pH 6.0–8.0.
RESULTS AND DISCUSSION
Dead Volume Measurement using a Dead Column
The initial experiments to measure the column dead volume
(V0) were based on the use of a dead column that was packed
with Toyopearl AF-Formyl particles without any immobilised
protein, the currently recommended and the most practiced
technique. The retention volume for a number of different
proteins and acetone were measured and the V’p/V’a ratio’s
calculated. These experiments were run at a range of pH’s
and NaCl concentrations. According to Tessier et al. (23) using
a NaCl concentration >0.8 M should eliminate protein-
surface interactions and thus protein injections at <0.8 M
NaCl would show interactions in their chromatograms.
Overall it presumed that the dead columns will provide the
same information as ideal non-interacting molecules of the
same size as the protein. In testing the dead column, a number
of pH conditions were evaluated between pH 4.5 and 8.0.
Catalase and BSA showed no or minimal differences in the
retention volume for the different pH conditions at 0.8 M
NaCl. Lysozyme showed a slight increase in retention volume
at pH 4.5 but the mAb showed quite an extensive increase in
retention volume when this pH was reached. In general the
conditions pH 6.0 and 8.0 showed the same retention volume
for both lysozyme and mAb.
Figure 1 shows that catalase and BSA have a retention
behaviour that is independent of pH. The pH independent
behaviour of these proteins is consistent with the hypothesis
previously advanced that 0.8 M NaCl is able to shield the
protein-surface electrostatic interactions (23). However, for
mAbs, and a lesser extent lysozyme, there is a clear dependen-
cy of retention volume with pH. This observation is very sig-
nificant. Firstly, it implies that electrostatic interactions be-
tween the proteins were not fully shielded by the 0.8 M
NaCl of electrolyte present in the protein solutions. Whilst
secondly, it shows that dead volume measurements can be
both pH and protein-column dependent.
In order to confirm if this was a particle specific effect,
another dead column was packed with Toyopearl AF-
Amino particles and the same experimental method used.
This column was used to minimise the direct interactions be-
tween surface groups that could lead to a covalent linkage.
Figure 2 shows that for all 4 proteins retention on the
Amino dead column was constant and independent of pH,
in contrast to that shown in Fig. 1.
The results from Figs. 1 and 2 show unequivocally that
there can be specific interactions between the proteins and
the dead column packing phase, and therefore the choice of
dead column packing phase needs to proceed with care if it is
to accurately represent the dead volume. Furthermore, in the
case of larger injection sizes with high concentrations, there
would also a concomitant risk of having protein irreversibly
immobilised onto the column during the actual SIC experi-
ments as proteins have previously been immobilised on
packed columns in the presence of suitable reagents (45).
Theoretically, during the immobilisation procedure for lyso-
zyme and mAb the amine groups on the proteins form cova-
lent bonds with the aldehyde groups on the Toyopearl AF-
Formyl particles, and indeed such reactions may account for
the data shown in Fig. 1 for lysozyme and mAb. However,
though catalase and BSA can bind to the amine groups avail-
able on the Toyopearl AF-Amino particles, no evidence of
such interactions was observed for these dead column
experiments. It has previously been shown that protein
immobilisation can be performed in pre-packed columns
by slowly passing the protein through the column (45, 46).
However, these injections are very small in size and in such
cases the amount of protein that would be immobilised would
be insignificant.
Figure 3a and b shows the effect of lysozyme injected on the
two dead column. The peaks displayed in Fig. 3a shows a
minimum shift in retention time for pH values ≤6.0 with no
direct shifts seen in Fig. 3b. In Fig. 3a the shift in retention
time (peak maximum) is from 4.70 to 5.16 min with decreas-
ing pH, which causes V’p/V’a on average to change from 0.97
to 1.04 (first moment) and from 0.92 to 1.00 (peak maximum).
In Fig. 3b, V’p/V’a is 0.91–0.915 (first moment) and 0.87–
0.873 (peak maximum), which typify the errors found for dif-
ferent columns and injections in this study.
Figure 4a shows a more significant shift in the SIC chro-
matograms for mAbs compared to those shown in Fig. 3a.
The mAb chromatograms are highly dependent on the solu-
tion pH when eluted through a AF-Formyl column. Figure 4b
shows that the mAb retention is independent on pH, in
a similar fashion to 3b presented before for the amino
column. The retention time on Fig. 4a changes from
4.15 to 5.90 min (peak maximum). This leads to V’p/V’a
varying on average from 0.89 to 1.29 (first moment) and
0.81–1.10 (peak maximum). However, in Fig. 4b, V’p/V’a
changes between 0.89 and 0.91 (first moment), and 0.81 and
0.83 (peak maximum), which are consistent with uncertainties
for this study.
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The retention shifts seen in Figs. 3a and 4a are due to the
mAbs and lysozyme interactions with AF Formyl particles. For
mAb, the major change in retention time/volume was ob-
served first at pH 5.0 and then pH 4.5, which indicated stron-
ger interactions at lower solution pH’s. This highlights the
significant risk that protein specific interaction with the col-
umn packing can occur in dead columns.
Traditionally for dead volume determinations using a dead
column, the NaCl concentration was 0.8 M (23). As it was
established that dead volumes could be directly dependent
on pH, the effects of NaCl concentration were also evaluated
here. Dead volume as a function of NaCl concentration was
investigated at a pH 4.5, where mAb and lysozyme indicated
the strongest interactions with the column packing.
Figure 5a shows that the NaCl concentration has a signif-
icant effect on mAb retention. It has been previously reported
that the column matrix (resin particles) could participate in
specific interactions with the protein if the salt concentration
is too low (31, 41). These interactions can be assumed to occur
at a NaCl concentration of 0.2 M or less, where the V’p/V’a
values are higher. At this concentration there was a large
variability in the retention volumes. In Fig. 5amAb shows that
increasing NaCl concentrations results in increasing retention
volume variations which has also been reported by other
workers (18). In Fig. 5b, the mAb retention does not vary
much with NaCl concentration, which also supports the lower
level of specific interactions with the Toyopearl AF-Amino
columns.
AF-Formyl Dead Column
Lysozyme First Moment
Lysozyme Peak Maximum
BSAFirst Moment
BSA Peak Maximum
pH 8
pH 6
pH 4.5
Catalase First Moment
Catalase Peak Maximum
mAb First Moment
mAb Peak Maximum
0.6 0.8 1.0 1.2 1.4
V'p / V'a
Fig. 1 Protein Retention
behaviour on a Toyopearl AF-
Formyl dead column under different
pH conditions (0.8 M NaCl).
AF-Amino Dead Column
Lysozyme First Moment
Lysozyme Peak Maximum
BSAFirst Moment
BSA Peak Maximum
pH 8
pH 6
pH 4.5
Catalase First Moment
Catalase Peak Maximum
mAb First Moment
mAb Peak Maximum
0.6 0.8 1.0 1.2 1.4
V'p / V'a
Fig. 2 Protein retention behaviour
on a Toyopearl AF-Amino dead
column under different pH
conditions (0.8 M NaCl).
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Figure 6a displays the effects of NaCl concentration for
lysozyme on a Toyopearl AF-Formyl column. Similarly to
Fig. 5a, at a NaCl concentration of 0.2 M or less the interac-
tions are increasing again, possibly due to interactions with the
matrix.
The least specific protein-column interactions may be as-
sumed to occur where V’p/V’a is the smallest. This occurs at
approximately 0.4 M NaCl for both columns with mAbs, and
for lysozyme at 0.4–0.6 M. Peak maximum for lysozyme has
its minimum at 0.6 M, whereas the first moment analysis give
a minimum at 0.4 M.
Usually, the dead volume is measured on a dead column
under the same solution conditions as the SIC experiments.
However, as revealed in this study, not all dead columns be-
have in an inert fashion as has been previously presumed.
Therefore, the purpose and effectiveness of using dead col-
umns needs to be carefully considered. If the purpose of the
dead column is to allow an accurate dead volume
measurement by mimicking a non-interacting molecule of
the same hydrodynamic volume of the protein, then many
factors such as the column packing, salt concentration and
pH need to be taken into account in order to achieve a true
non-interacting combination. Here, it is shown that
attractive interactions can be prevalent between the
protein and the matrix at lower pH’s within certain
dead columns. Whether there is also scope for repulsive
interactions between the protein and the dead column
matrix is harder to determine. If the purpose of the
dead volume instead is allow accurate SIC retention
data by allowing all interactions with just the matrix to
be determined, e.g., if the column is not fully immobilised,
then the same column and conditions can be used without
taking into account of possible interactions. However, this will
not entail an absolute dead volume and for best results many
blank or reference experiments will need to be run, one for
each condition of the SIC experiment.
Fig. 3 Chromatograms for lysozyme injections on a Toyopearl AF-Formyl
column (a) and a Toyopearl AF-Amino column (b) under different pH condi-
tions (0.8 M NaCl).
Fig. 4 Chromatograms for mAb injections on a Toyopearl AF-Formyl col-
umn (a) and a Toyopearl AF-Amino column (b) under different pH conditions
(0.8 M NaCl).
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Dead Volume Measurement using a Non-Interacting
Probe Molecule
Another established way of estimating the dead volume is to
employ a dextran MW standard which is same size as the
protein molecule of interest, as the non-interacting molecule.
This species is then used with the actual protein immobilised
SIC column. For example, a dextran standard of 50 kDa has
been established as the same effective size of the mAb allowing
evaluation of the dead volume (41). Previously reported dead
volumes for mAb are compared with the 50 kDa dextran
standard as shown in Table I below. The first column shows
the originally measured dead volume for mAb using the
Toyopearl AF-Formyl column, sodium acetate buffer
pH 4.5, 0.8 M NaCl. The second column includes an
optimised dead volume for the same pH sodium acetate buffer
as before, but using the Toyopearl AF-Amino column and the
NaCl concentration of 0.4 M, with the lowest retention. The
third column contains the average dextran/acetone retention
of a number of injections of the 50 kDa dextran standard
averaged for two mAb immobilised SIC columns under var-
ious pH and salt conditions.
Different dextran molecular weight standards were
injected into several dead columns such as the AF-Formyl
column and the AF-Amino column, as well as a mAb
immobilised SIC columns to investigate possible interactions
with the matrix. The dextran retention volumes were com-
pared to acetone injections for the different columns to ac-
count for any difference in packing characteristics or bed
height between the columns. The retention behaviour of the
dextran standards were shown to be independent of buffer
conditions used and gave consistent results between the two
dead columns and the mAb column. This data indicated min-
imal interactions with the matrix and therefore offers a good
alternative method for estimating the dead volume.
The only drawback with using dextran standards is the
uncertainty of knowing whether the dextran standard chosen
has of the same hydrodynamic volume as the protein of
Fig. 5 Retention ratios for mAb injections on a Toyopearl AF-Formyl column
(a) and on a Toyopearl AF-Amino column (b) as a function of NaCl concen-
trations (20 mM sodium acetate pH 4.5).
Fig. 6 Retention ratios for lysozyme injections on a Toyopearl AF-Formyl
column (a) and on a Toyopearl AF-Amino column (b) as a function of NaCl
concentrations (20 mM sodium acetate pH 4.5).
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interest. This size was previously estimated using a Superdex
200 GL column by comparing the retention volume of the
dextran standards with the retention volume of the mAb, con-
cluding that the 50 kDa dextran standards were the closest size
equivalent to a 142 kDa mAb based on the similarity in reten-
tion volumes (41). However, the need to estimate the size of
the dextran standards and comparing them to the SIC pro-
teins by estimating the retention volume in a size exclusion
column means that the use of dextran standards is not neces-
sarily economically advantageous compared to the use of dead
columns.
The k’ is calculated using Eq. 3 with Vp defined as 2.35 ml.
In Table I the comparisons between the different calcula-
tions of the dead volumes demonstrates that a dead volume
estimate where specific protein-support interactions are
negligible are the same, within experimental error, to
the dead volume obtained by the dextran standard method,
which leads to approximately the same values for k’. These
dead volume results have also been used for calculating the
variations in B2 as a function of the dead volume estimate
used.
In Fig. 7 by comparing dextran and acetone retention on a
mAb immobilised column it is seen that the dextran standard
has a peak maximum and a first moment retention time less
than acetone. Protein and polymer peaks are wider than ace-
tone peaks, based on peak width at ½ height basis as noted
previously (44).
In addition a simple partitioning model was published by
Binabaji et al. (41) to determine the protein retention volume
for a resin with uniform cylindrical pores:
V
0
Protein ¼ V
0
Pore 1−
rs
R
 2
þ V 0Void
Where rs is the protein radius, R is the pore radius, VPore
′ is
the pore space and VVoid
′ is the interparticle void volume.
Binabaji et al. (41) defined rs to be 5.43 nm for the mAb
modelled by the dextran standard and R to be 73.9 nm for
the resin used in this study. The acetone retention volume per
ml of packed resin was determined to be 1.4ml and is assumed
to be equally distributed between the pore space and void
volume. For an immobilised protein column of the same size
with an average of 32% surface coverage the pore volume
accessible is reduced with 0.075 ml and R reduced to
68.47 nm according to the model. This gives a protein reten-
tion volume of 1.23 ml and a VP/Va of 0.878, confirming the
result obtained by the AF-Amino column.
The importance of using accurate and robust estimates for
the dead volume in determining B2 values cannot be over
emphasised. Erroneous dead volumes lead directly to inaccu-
rate estimates of B2 values. The dead volume estimates from
Table I are shown in Fig. 8 where B2 of themAb is determined
as a function of increasing NaCl concentrations. The B2 esti-
mates in this experiment are decreasing for increasing NaCl
Table I Summary for Different
Methods to Calculate the Dead
Volume
Dead column method Dead column method Dextran method
AF-Formyl column AF-Amino column Dextran 50 kDa
V’p/V’a or VDextran/ Va 1.285 (±0.033) 0.87 (±0.00) 0.86 (±0.01)
Dead Volume (ml) 2.844 1.918 1.919
k’ (Vp=2.35 ml) −0.174 (±0.022) 0.225 (±0.002) 0.225 (±0.009)
Fig. 7 Retention of acetone and dextran 50 kDa on a mAb SIC
column.
Fig. 8 B2 values for different NaCl concentrations depending on the dead
volume estimates used (20 mM sodium acetate pH 4.5).
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concentrations because of increasing charge shielding and
therefore subsequent loss of electrostatic stability. However,
the actual B2 values estimated vary substantially depending
upon the dead volume used. Figure 8 provides three different
estimated B2 values based on the three dead volumes deter-
mined in this study, where the second and third dead volumes
are very similar (Table I).
As seen in Fig. 8, the increased dead volume estimates using
the original AF-Formyl column will lead to only positive B2
values being estimated since the protein retention volume is in
all the cases less than the dead volume. This result will indicate
that only repulsive interactions are present between the mAbs
at all NaCl concentrations. The B2 values estimated using the
optimised dead volume from the AF-Amino column (and
0.4 M NaCl) and from the dextran standard (50 kDa) are
the same within experimental error. The error bars
displayed are calculated from the standard deviation of
dead volumes observed. These B2 values indicate, on
the contrary, that predominantly attractive interactions
between the mAbs occur, apart from at low NaCl con-
centrations. The difference in B2 based on the dead
volume ranges from 6 to 9 units depending on the salt
concentration, which can lead to a significant error in
estimating the B2. The use of the dextran standard con-
firms the result of the dead volume from the AF-Amino
dead column as the non-interacting molecule previously
seen as a good alternative to dead columns (41).
CONCLUSIONS
The use of a dead column is currently the most com-
mon method used to estimate dead volume for SIC. It
has been previously assumed that if salt concentrations
were ≥0.8 M, any protein-particle interactions present
would be negligible for column dead volume measure-
ments. However, in this investigation across a wide
range of pH and salt conditions for a number of pro-
teins it has been shown that certain proteins, in this
case a mAb, specific interactions with the particles at
lower pH values can be significant. The dead volume
for a various mAb SIC columns was investigated across
a range of different conditions including two different
types of dead columns. An optimal dead volume was
chosen where the mAb showed the smallest retention
with the column packing. This column dead volume
was then compared to the dead volume estimated using
a non-interacting dextran standard with the same esti-
mated hydrodynamic volume as the mAb. This
optimised column dead volume and the dead volume
derived from the dextran standard retention proved to
be the same within experimental error. This result indi-
cates that using the same type of particles that is
generally used as a SIC chromatographic support for a
certain protein when immobilised can be an unsuitable
choice as a SIC dead column under certain conditions
due to specific interaction. Finally, the B2 values deter-
mined from SIC were compared for the different dead
volumes estimates, which highlights the importance of
using accurate dead volume estimates in SIC. In gener-
al, greater care must be exercised when estimating dead
volumes for SIC studies, otherwise substantial errors in
virial coefficients may result.
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